Prescription medicine
Trastuzumab-qyyp Brand names: Trazimera
Trastuzumab-qyyp (Trazimera) is a prescription medicine with an FDA approval on record since 2019. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: trastuzumab-qyyp labels on DailyMed; the BLA 761081 record on Drugs@FDA; every trastuzumab-qyyp label on DailyMed.
Highlights of the record
no current FDA label; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
The label in openFDA carries no indications section.
Forms and strengths
Kit.
On the market
- Earliest approval on file
- March 11, 2019 Trazimera, Pfizer Inc; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 381 through July 30, 2026
Is there a generic for trastuzumab-qyyp (Trazimera)?
No generic trastuzumab-qyyp is approved (Drugs@FDA, October 8, 2026).
- 2019 earliest approval on file
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do FAERS reports show for trastuzumab-qyyp?
The FDA Adverse Event Reporting System holds 381 reports that list trastuzumab-qyyp among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 40 are coded as a death and 69 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other her2/neu receptor antagonists
- the pharmacologic class, with prices and generics
- Trastuzumab-qyyp side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other